Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D)
Part of paid clinical trials in Milwaukee, Wisconsin.
- Sponsor
- Medical College of Wisconsin
- Study ID
- NCT07434544
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Non-Nutritive Sweetener
- Type 1 Diabetes
- Type 1 Diabetes Mellitus
- type1diabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 15 Years - 24 Years
- Healthy Volunteers
- Not accepted
Interventions
- Cherry Sports Drink — DIETARY_SUPPLEMENT12 oz bottle (1 1/2 cups) of Gatorade G Zero Glacier Cherry™ Sports Drink
Study Details
This project will apply a novel non-nutritive sweetener (NNS) dietary assessment tool with measurement of circulating NNS levels in a pediatric population, allowing correlation of NNS exposure to clinically meaningful cardiometabolic health outcomes.
Key Dates
- Start date
- Jun 1, 2026
- Status verified
- Jan 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Treatment GroupSports Drink - Participants will drink a cherry sports drink within 10 minutes.
Primary Outcome Measure
Change in "in vivo" endothelial function and vascular stiffness [ Time Frame: 2 years (duration of study) ]
Central Contacts
- Susanne M Cabrera, MD414-955-4903
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Susanne M Cabrera, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Milwaukee, WI
By condition
By specialty
By research site
Related Studies
- Genetics Of Autoimmunity In Type I DiabetesRecruiting · Medical College of Wisconsin · Milwaukee, Wisconsin
- TArgeting Type 1 Diabetes Using POLyamines (TADPOL)PHASE2 · Recruiting · Emily K. Sims · Aurora, Colorado
- An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney TransplantPHASE3 · Recruiting · Vertex Pharmaceuticals Incorporated · Philadelphia, Pennsylvania
- Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft LossRecruiting · Rodolfo Alejandro · Miami, Florida